BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 22117639)

  • 1. Medical and endoscopic therapy of primary sclerosing cholangitis.
    Weismüller TJ; Lankisch TO
    Best Pract Res Clin Gastroenterol; 2011 Dec; 25(6):741-52. PubMed ID: 22117639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment options for primary sclerosing cholangitis.
    Sinakos E; Lindor K
    Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):473-88. PubMed ID: 20678020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?
    Hay JE
    Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S9-17. PubMed ID: 9742489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
    Boberg KM; Schrumpf E
    Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: current management of primary sclerosing cholangitis.
    Cullen SN; Chapman RW
    Aliment Pharmacol Ther; 2005 Apr; 21(8):933-48. PubMed ID: 15813829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary sclerosing cholangitis.
    Geonzon-Gonzales MR
    Gastroenterol Nurs; 2007; 30(2):102-5; quiz 105-7. PubMed ID: 17440311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The medical management of primary sclerosing cholangitis.
    Cullen SN; Chapman RW
    Semin Liver Dis; 2006 Feb; 26(1):52-61. PubMed ID: 16496233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel developments in IBD-related sclerosing cholangitis.
    Ponsioen CY
    Best Pract Res Clin Gastroenterol; 2011 Apr; 25 Suppl 1():S15-8. PubMed ID: 21640925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary sclerosing cholangitis and primary biliary cirrhosis. How effective is medical therapy?
    Fennerty MB
    Postgrad Med; 1993 Nov; 94(6):81-8; 92. PubMed ID: 8234100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis.
    Holtmeier J; Leuschner U
    Digestion; 2001; 64(3):137-50. PubMed ID: 11786661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of cholestatic liver disease].
    Pleşa A
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):733-6. PubMed ID: 14756010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Possible treatment modalities of primary sclerosing cholangitis].
    Lengyel G; Tulassay Z
    Orv Hetil; 2005 Dec; 146(49):2479-83. PubMed ID: 16398312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective single-center review of primary sclerosing cholangitis in children.
    Miloh T; Arnon R; Shneider B; Suchy F; Kerkar N
    Clin Gastroenterol Hepatol; 2009 Feb; 7(2):239-45. PubMed ID: 19121649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study.
    Stiehl A; Rudolph G; Sauer P; Benz C; Stremmel W; Walker S; Theilmann L
    J Hepatol; 1997 Mar; 26(3):560-6. PubMed ID: 9075663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary sclerosing cholangitis.
    Zein CO; Lindor KD
    Semin Gastrointest Dis; 2001 Apr; 12(2):103-12. PubMed ID: 11352117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary sclerosing cholangitis in pregnancy refractory to ursodeoxycholic acid treatment: a case report.
    Leftwich H; Fang YM; Borgida A; Crombleholme W
    J Reprod Med; 2010; 55(11-12):517-9. PubMed ID: 21291041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary sclerosing cholangitis: summary of a workshop.
    LaRusso NF; Shneider BL; Black D; Gores GJ; James SP; Doo E; Hoofnagle JH
    Hepatology; 2006 Sep; 44(3):746-64. PubMed ID: 16941705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenetic aspects of primary sclerosing cholangitis: implications for therapeutic strategies.
    van Milligen de Wit AW; van Deventer SJ; Tytgat GN
    Am J Gastroenterol; 1995 Jun; 90(6):893-900. PubMed ID: 7771416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on primary sclerosing cholangitis.
    Karlsen TH; Schrumpf E; Boberg KM
    Dig Liver Dis; 2010 Jun; 42(6):390-400. PubMed ID: 20172772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of autoimmune and cholestatic liver disorders.
    Krok KL; Munoz SJ
    Clin Liver Dis; 2009 May; 13(2):295-316. PubMed ID: 19442920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.